🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Steven Cohen’s HCAT Holdings & Trades

First Buy
Q1 2020
Duration Held
22 Quarters
Largest Add
Q3 2023
+1.49 M Shares
Current Position
19,929 Shares
$34,477 Value

Steven Cohen's HCAT Position Overview

Steven Cohen (via Point72 Asset Management, L.P.) currently holds 19,929 shares of Health Catalyst, Inc. (HCAT) worth $34,477, representing 0.00% of the portfolio. First purchased in 2020-Q1, this long-term strategic position has been held for 22 quarters.

Based on 13F filings, Steven Cohen has maintained a strategic position in HCAT, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 1.49 M shares. Largest reduction occurred in Q1 2024, reducing 2.12 M shares.

Analysis based on 13F filings available since 2013 Q2

Steven Cohen's Health Catalyst (HCAT) Holding Value Over Time

Track share changes against reported price movement

Quarterly Health Catalyst (HCAT) Trades by Steven Cohen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +19,929 New Buy 19,929 $1.73
Q1 2025 -215,160 Sold Out 0 $0.00
Q4 2024 -301,774 Reduce 58.38% 215,160 $7.07
Q3 2024 +211,805 Add 69.41% 516,934 $8.14
Q2 2024 -1.73 M Reduce 84.99% 305,129 $6.39
Q1 2024 -2.12 M Reduce 51.09% 2.03 M $7.53
Q4 2023 +273,514 Add 7.04% 4.16 M $9.26
Q3 2023 +1.49 M Add 62.01% 3.88 M $10.12
Q2 2023 +1.01 M Add 72.85% 2.4 M $12.50
Q1 2023 -179,100 Reduce 11.44% 1.39 M $11.67
Q4 2022 -362,400 Reduce 18.79% 1.57 M $10.63
Q3 2022 +948,234 Add 96.74% 1.93 M $9.70
Q2 2022 +767,231 Add 360.31% 980,166 $14.49
Q1 2022 +212,935 New Buy 212,935 $26.13
Q4 2021 -202,194 Sold Out 0 $0.00
Q3 2021 +6,008 Add 3.06% 202,194 $50.01
Q2 2021 +196,186 New Buy 196,186 $55.51
Q1 2021 -322,388 Sold Out 0 $0.00
Q4 2020 -490,591 Reduce 60.34% 322,388 $43.53
Q3 2020 -265,103 Reduce 24.59% 812,979 $36.60
Q2 2020 +279,616 Add 35.02% 1.08 M $29.17
Q1 2020 +798,466 New Buy 798,466 $26.15

Steven Cohen's Health Catalyst Investment FAQs

Steven Cohen first purchased Health Catalyst, Inc. (HCAT) in Q1 2020, acquiring 798,466 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Steven Cohen has held Health Catalyst, Inc. (HCAT) for 22 quarters since Q1 2020.

Steven Cohen's largest addition to Health Catalyst, Inc. (HCAT) was in Q3 2023, adding 3,883,852 shares worth $39.3 M.

According to the latest 13F filing for Q3 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 19,929 shares of Health Catalyst, Inc. (HCAT), valued at approximately $34,477.

As of the Q3 2026 filing, Health Catalyst, Inc. (HCAT) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.

Steven Cohen's peak holding in Health Catalyst, Inc. (HCAT) was 4,157,366 shares, as reported at the end of Q4 2023.